Registry for patients undergoing left atrial appendage occlusion procedures
Left Atrial Appendage Occlusion Registry (LAAO Registry)
This study collects information from patients who have a procedure to close off a part of the heart to see if it helps reduce their risk of stroke from atrial fibrillation.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | American College of Cardiology Academic / other |
| Locations | 1 site (Washington, District of Columbia) |
| Trial ID | NCT02699957 on ClinicalTrials.gov |
What this trial studies
The Left Atrial Appendage Occlusion Registry (LAAO Registry) collects data on patients who undergo procedures to occlude the left atrial appendage, aimed at reducing stroke risk in individuals with atrial fibrillation. Participating hospitals submit patient-level data quarterly to the American College of Cardiology Foundation's National Cardiovascular Data Registry. The registry aims to optimize patient outcomes through evidence-based guidelines, improve quality and safety in clinical practice, and facilitate risk-adjusted assessments for comparison with nationwide data. It serves as a valuable resource for quality improvement and clinical research.
Who should consider this trial
Good fit: Ideal candidates for this registry are adult patients aged 18 and older who are undergoing percutaneous or epicardial left atrial appendage occlusion procedures.
Not a fit: Patients who are not undergoing left atrial appendage occlusion procedures will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance the management and outcomes of patients undergoing left atrial appendage occlusion procedures.
How similar studies have performed: Other studies utilizing registry data for procedural outcomes have shown success in improving patient care and outcomes, indicating that this approach is validated.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients, 18 years and older, undergoing percutaneous or epicardial left atrial appendage occlusion procedures Exclusion Criteria: * None
Where this trial is running
Washington, District of Columbia
- American College of Cardiology/National Cardiovascular Data Registry (NCDR) — Washington, District of Columbia, United States (Recruiting)
Study contacts
- Study coordinator: Mark Fox, CHC, CHPC
- Email: mfox@acc.org
- Phone: 202-375-6305
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.